share_log

Thinking about buying stock in Arcus Biosciences, Capricor Therapeutics, Orphazyme, Sundial Growers, or Citius Pharmaceuticals?

PR Newswire ·  Jun 23, 2021 20:30

NEW YORK,June 24, 2021/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RCUS, CAPR, ORPH, SNDL, and CTXR.

20210624203156998d246w2h2op1xjwp

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.RCUS:https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RCUS&prnumber=062420211CAPR:https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CAPR&prnumber=062420211ORPH:https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ORPH&prnumber=062420211SNDL:https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SNDL&prnumber=062420211CTXR:https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CTXR&prnumber=062420211

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

20210624203204252d2468jsruv02a9i

View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-arcus-biosciences-capricor-therapeutics-orphazyme-sundial-growers-or-citius-pharmaceuticals-301319375.html

SOURCE InvestorsObserver

rt.gif?NewsItemId=CG23228&Transmission_Id=202106240830PR_NEWS_USPR_____CG23228&DateId=20210624

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment